Your Daily Pharma Scoop: Everybody’s Gilead Problem, Halozyme’s Further Progress, ZIOPHARM’s Gene Therapy – Seeking Alpha
|
Your Daily Pharma Scoop: Everybody’s Gilead Problem, Halozyme’s Further Progress, ZIOPHARM’s Gene Therapy
Seeking Alpha ZIOPHARM’s gene therapy Ad-RTS-hIL-12 with veledimex commences trials in pediatric patients with brain tumors. This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare … |
PR Newswire (press release) |
Need for speed makes genome editing efficient, if not better – Phys.org
Phys.Org When a CRISPR-Cas9 protein finds its target, it first finds a spacer sequence known as PAM and then searches adjacent DNA to see if it matches Cas9’s guide … Breakthrough CRISPR/Cas9 Rat Model TechnologyPR Newswire (press release) |